Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-SARS-CoV-2 Plasma in Hospitalized Non-ICU COVID-19 Patients
NCT04467151Phase 2Withdrawn
- Start
- Oct 2020
- Primary completion
- Oct 2021
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of COVID-19 convalescent plasma in coronavirus disease 2019 (COVID-19). Planned start Oct 2020; status: withdrawn.
02
Drugs
COVID-19 convalescent plasma
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04467151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04467151.